Sheila Weinmann to Biomarkers, Tumor
This is a "connection" page, showing publications Sheila Weinmann has written about Biomarkers, Tumor.
Connection Strength
0.850
-
Validation of a Genomic Classifier for Predicting Post-Prostatectomy Recurrence in a Community Based Health Care Setting. J Urol. 2016 06; 195(6):1748-53.
Score: 0.463
-
Validation of the Decipher Test for Predicting Distant Metastatic Recurrence in Men with High-risk Nonmetastatic Prostate Cancer 10 Years After Surgery. Eur Urol Oncol. 2019 09; 2(5):589-596.
Score: 0.144
-
Individual Patient-Level Meta-Analysis of the Performance of the Decipher Genomic Classifier in High-Risk Men After Prostatectomy to Predict Development of Metastatic Disease. J Clin Oncol. 2017 Jun 20; 35(18):1991-1998.
Score: 0.127
-
Stem Cell Marker Expression in Early Stage Colorectal Cancer is Associated with Recurrent Intestinal Neoplasia. World J Surg. 2020 10; 44(10):3501-3509.
Score: 0.040
-
Loss of myoepithelial calponin-1 characterizes high-risk ductal carcinoma in situ cases, which are further stratified by T cell composition. Mol Carcinog. 2020 07; 59(7):701-712.
Score: 0.039
-
Transcriptomic Heterogeneity of Androgen Receptor Activity Defines a de novo low AR-Active Subclass in Treatment Naïve Primary Prostate Cancer. Clin Cancer Res. 2019 11 15; 25(22):6721-6730.
Score: 0.038